Research Grant
[Cite as http://purl.org/au-research/grants/nhmrc/1027125]Researchers: Dr Michael Cater (Principal investigator)
Brief description The overarching aim of this project is to evaluate a potential therapy for prostate cancer, which targets a distinct characteristic of the disease 'elevated copper'. Our copper-based drugs in the laboratory selectively destroy cancerous prostate cells without harming normal cells. We will verify whether these drugs work in the body where the environment is more complex. Proof of this principle will open up a new area of research and provide a novel therapeutic approach for prostate cancer.
Funding Amount $AUD 314,154.32
Funding Scheme Project Grants
Notes New Investigator Grant
- PURL : http://purl.org/au-research/grants/nhmrc/1027125
- nhmrc : 1027125